Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Mater Sci Mater Med ; 29(9): 142, 2018 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-30121849

RESUMEN

Chitosan (CS) based nanoparticles (NPs) have several advantages in delivering drugs. They are usually prepared in a micro-emulsion solvent system but this route can leave significant levels of potentially harmful organic solvent residue in the NPs. In this study, we prepared CS based nanocomposites using charge driven self-assembly in an aqueous buffer, thus avoiding the use of organic solvents. Doxorubicin (DOX) was covalently attached to positive charged CS with a legumain substrate peptide to confer targeted drug release property, since legumain is often overexpressed in tumors or tumor associated micro environments. This DOX prodrug solution interacted with negative charged methoxyl poly (ethylene glycol)-block-poly (glutamic acid) copolymer (PEG-PGA) in an aqueous buffer forming nanocomposite with a regular morphology. The particle size and zeta potential of these NPs was regulated by the addition of different PEG-PGA concentrations into the DOX prodrug solution. Due to its potential for legumain triggered release, this DOX NP exhibited enhanced cytotoxicity against choroidal melanoma cell line (Mum-2C) and reduced cytotoxicity on normal human corneal epithelial cells (HCEC), suggesting a good potential for enhanced targeted delivery of chemotherapeutic agents. A chitosan based nanocomposite with legumain sensitive properties are rapidly controllable prepared in aqueous buffer by charge driven self-assembly strategy, without using micro-emulsion solvent system and cross-linking agents.


Asunto(s)
Antineoplásicos/administración & dosificación , Quitosano/química , Cisteína Endopeptidasas/administración & dosificación , Cisteína Endopeptidasas/química , Nanocompuestos/química , Neoplasias/metabolismo , Animales , Línea Celular Tumoral , Supervivencia Celular , Córnea/metabolismo , Doxorrubicina/administración & dosificación , Sistemas de Liberación de Medicamentos , Liberación de Fármacos , Células Epiteliales/citología , Células HeLa , Humanos , Ratones , Microscopía Electrónica de Transmisión , Nanopartículas/química , Compuestos Orgánicos/química , Tamaño de la Partícula , Péptidos/química , Polímeros/química , Profármacos/administración & dosificación , Profármacos/química , Solventes/química
2.
Bioresour Technol ; 155: 57-62, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24413482

RESUMEN

Chemical liquid deposition (CLD) with KH550, TEOS and methyl silicone oil as the modifiers was used to modify ZSM-5 and deposit its external acid sites. The characteristics of modified catalysts were tested by catalytic conversion of biomass pyrolysis-derived compounds. The effects of different modifying conditions (deposited amount, temperature, and time) on the product yields and selectivities were investigated. The results show KH550 modified ZSM-5 (deposited amount of 4%, temperature of 20°C and time of 6h) produced the maximum yields of aromatics (24.5%) and olefins (16.5%), which are much higher than that obtained with original ZSM-5 catalyst (18.8% aromatics and 9.8% olefins). The coke yield decreased from 44.1% with original ZSM-5 to 26.7% with KH550 modified ZSM-5. The selectivities of low-molecule-weight hydrocarbons (ethylene and benzene) decreased, while that of higher molecule-weight hydrocarbons (propylene, butylene, toluene, and naphthalene) increased comparing with original ZSM-5.


Asunto(s)
Biocombustibles , Biomasa , Hidrocarburos/aislamiento & purificación , Lignina/química , Zeolitas/química , Catálisis , Calor , Propiedades de Superficie , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA